Global Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) Pipeline Review 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H1 2016" report to their offering.

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) pipeline Target constitutes close to 22 molecules. Out of which approximately 18 molecules are developed by Companies and remaining by the Universities

Institutes.

Interleukin 10 - Pipeline Review, H1 2016, outlays comprehensive information on the Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) Interleukin 10 (IL-10) also known as human cytokine synthesis inhibitory factor (CSIF) is an anti-inflammatory cytokine. IL-10 regulates growth or differentiation of B cells, NK cells, cytotoxic and helper T cells, mast cells, granulocytes, dendritic cells, keratinocytes, and endothelial cells. IL-10 plays a key role in differentiation and function of a newly appreciated type of T cell, the T regulatory cell, which prominently control immune responses and tolerance.

This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. The molecules developed by Companies in Phase II, Phase I and Preclinical stages are 3, 2 and 13 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 4 molecules, respectively.

Furthermore, this report also reviews key players involved in Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted therapeutics development, features dormant and discontinued projects and latest news and press releases.

Companies Mentioned

  • BioMAS Ltd.
  • Biotest AG
  • enGene, Inc
  • Intrexon Corporation
  • LEO Pharma A/S
  • Merck & Co., Inc.
  • P2D Bioscience
  • Pfizer Inc.
  • SK Biopharmaceuticals Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/xrc4vf/interleukin_10

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders Drugs